Adaptin Bio (APTN) Notes Payables (2022 - 2024)

Adaptin Bio (APTN) has 3 years of Notes Payables data on file, last reported at $544957.0 in Q4 2024.

• For the quarter ending Q4 2024, Notes Payables rose 570.97% year-over-year to $544957.0; the trailing twelve-month figure through Dec 2024 stood at $544957.0 (up 570.97% YoY), and the FY2024 full-year result was $544957.0, up 570.97% from the prior year.
• Notes Payables grew to $544957.0 in Q4 2024, from $137764.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $544957.0 in Q4 2024 to a low of $304.0 in Q4 2022.
• A 3-year average of $140129.6 and a median of $81219.0 in 2023 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables soared 26616.78% in 2023 and surged 502.33% in 2024, its largest moves.
• Tracing APTN's Notes Payables over 3 years: stood at $304.0 in 2022, then soared by 26616.78% to $81219.0 in 2023, then surged by 570.97% to $544957.0 in 2024.
• Business Quant data shows APTN's Notes Payables at $544957.0 in Q4 2024, $137764.0 in Q3 2024, and $112572.0 in Q2 2024.